Evidence map›Paper›PMID 38799653›Full record

ArticleACS central science2024

Incorporation of Multiple β

Noah X Hamlish, Ara M Abramyan, Bhavana Shah, Zhongqi Zhang, Alanna Schepartz

Erratum issuedAbstract read
In one paragraph

Article in ACS central science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Expanding the Genetic Code with Lysine Aminoacylation.Journal of the American Chemical Society · 2026
    Article
  4. Co-Translational Incorporation ofJournal of the American Chemical Society · 2026
    Article
  5. Co-Translational Incorporation of (Journal of the American Chemical Society · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Peptide Backbone Editing via Post-Translational O to C Acyl Shift.Journal of the American Chemical Society · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Noah X HamlishDepartment of Molecular and Cellular Biology, University of California, Berkeley, California 94720, United States.
Ara M AbramyanSchrödinger, Inc., San Diego, California 92121, United States.
Bhavana ShahProcess Development, Attribute Sciences, Amgen Inc., Thousand Oaks, California 91320, United States.
Zhongqi ZhangProcess Development, Attribute Sciences, Amgen Inc., Thousand Oaks, California 91320, United States.ORCID https://orcid.org/0000-0002-8326-6714
Alanna SchepartzDepartment of Molecular and Cellular Biology, University of California, Berkeley, California 94720, United States.ORCID https://orcid.org/0000-0003-2127-3932

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The programmed synthesis of sequence-defined biomaterials whose monomer backbones diverge from those of canonical α-amino acids represents the next frontier in protein and biomaterial evolution. Such next-generation molecules provide otherwise nonexistent opportunities to develop improved biologic therapies, bioremediation tools, and biodegradable plastic-like materials. One monomer family of particular interest for biomaterials includes β-hydroxy acids. Many natural products contain isolated β-hydroxy acid monomers, and polymers of β-hydroxy acids (β-esters) are found in polyhydroxyalkanoate (PHA) polyesters under development as bioplastics and drug encapsulation/delivery systems. Here we report that β

Identifiers

PMID38799653
PMCPMC11117724

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.